Summary Keywords HGF, MET, synaptogenesis, autism, cerebral ischemia, spinal cord injury, amyotrophic lateral sclerosis, multiple sclerosis Citation Desole C, Gallo S, Vitacolonna A, Montarolo F, Bertolotto A, Vivien D, Comoglio P and Crepaldi T (2021) HGF and MET: From Brain Development to Neurological Disorders
Using retinoids, vitamin C , and AHA/BHA exfoliants simultaneously creates compounding effects that intensify purging beyond what copper peptides alone would cause
Eli Lilly subsequently attempted to patent this as their discovery but it was rejected in court due to the prior publication by Bloom's group (Bloom email)
these effects are dose-dependent and resolve with dose reduction
Rather than defend high list prices, Lilly and Novo are using scale itself as the new moatturning volume into their competitive weapon
We still need to consider individual context, not just clinical guidelines